RENOVARO INC. - COMMON

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

02 Oct 2023 12:05:40 By Nasdaq GlobeNewswire

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

02 Oct 2023 09:25:00 By Nasdaq GlobeNewswire

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

29 Sep 2023 09:15:00 By Nasdaq GlobeNewswire

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

30 Aug 2023 09:15:00 By Nasdaq GlobeNewswire

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

21 Aug 2023 09:15:00 By Nasdaq GlobeNewswire

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

09 Aug 2023 09:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

23 Jun 2023 17:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

08 Jun 2023 08:45:00 By Nasdaq GlobeNewswire

Enochian BioSciences’ CEO Letter to Shareholders

03 Apr 2023 09:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

29 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

13 Mar 2023 08:30:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

23 Feb 2023 16:04:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

30 Nov 2022 17:20:12 By Nasdaq GlobeNewswire

Enochian BioSciences Forges Ahead With Focused Approach, Promising Future

24 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K

21 Oct 2022 17:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform

17 Oct 2022 08:30:00 By Nasdaq GlobeNewswire

Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor

25 Jul 2022 10:15:16 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data

01 Jul 2022 17:00:00 By Nasdaq GlobeNewswire

Scientific Leaders Agree on Promise of Enochian BioSciences

31 May 2022 08:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company

25 May 2022 16:20:30 By Nasdaq GlobeNewswire